Enovis (ENOV) Current Deferred Tax Assets (2010 - 2011)
Enovis (ENOV) reported Current Deferred Tax Assets of $9.4 million for Q4 2011, up 54.01% year-over-year from $6.1 million in Q4 2010, and up 47.82% quarter-over-quarter from $6.4 million in Q3 2011.
Enovis (ENOV) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends
Enovis (ENOV) has 2 years of Current Deferred Tax Assets data on file, last reported at $9.4 million in Q4 2011.
- Current Deferred Tax Assets for Q4 2011 came in at $9.4 million, up 54.01% year-over-year; the trailing twelve-month figure through Dec 2011 was $9.4 million (up 54.01% YoY), and the FY2011 annual result was $9.4 million, up 54.01% from the prior year.
- Current Deferred Tax Assets rose to $9.4 million in Q4 2011 per ENOV's latest filing, from $6.4 million in the prior quarter.
- Over five years, Current Deferred Tax Assets peaked at $9.4 million in Q4 2011 and troughed at $6.1 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Enovis | 1.24 Bn | 1.21 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 9.41 Mn |
| Dec 31, 2011 | 9.41 Mn |
| Sep 30, 2011 | 6.36 Mn |
| Sep 30, 2011 | 6.36 Mn |
| Jul 1, 2011 | 6.57 Mn |
| Jul 1, 2011 | 6.57 Mn |
| Dec 31, 2010 | 6.11 Mn |
| Dec 31, 2010 | 6.11 Mn |